Kinji Fuchikami

Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1

Toshiki Murata, Mitsuyuki Shimada, Sachiko Sakakibara et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 172 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +6

A selective novel low‐molecular‐weight inhibitor of I<i>κ</i>B kinase‐<i>β</i> (IKK‐<i>β</i>) prevents pulmonary inflammation and shows broad anti‐inflammatory activity

Karl Ziegelbauer, Florian Gantner, Nicholas W. Lukacs et al. · British Journal of Pharmacology · 2005 · 146 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 3: Orally active anti-inflammatory agents

Toshiki Murata, Mitsuyuki Shimada, Sachiko Sakakibara et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 121 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 2: Improvement of in vitro activity

Toshiki Murata, Mitsuyuki Shimada, Hiroshi KADONO et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis

Daiichiro Nakahara, Kinji Fuchikami, Norio Ozaki et al. · Brain Research · 1992 · 63 citations

Life Sciences, Neurobiology, Neuroscience +17